Literature DB >> 1875081

Hepatitis D anti-bodies in some HBs Ag positive in Saudis at Riyadh.

M Massoud1, O Helmy, W A Saleh.   

Abstract

This study was done on 212 male and female Saudi blood donors and those visiting the Outpatient Clinics in Al Ali General Hospital during the years 1987 to 1990. None of them had history of hepatitis and all were clinically free. The prevalence of anti-Delta Ab in hepatitis B surface antigen (HBs Ag) carriers was 17.6%. The existence of closely linked family ties and joint family systems, result in close contact between patients and other members of the family and hence the high prevalence rate in normal population (8%). Vaccination against Hepatitis B virus may be particularly necessary.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875081

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  4 in total

Review 1.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

2.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

3.  Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.

Authors:  Ghazi A Jamjoom; Mai M El-Daly; Esam I Azhar; Hind I Fallatah; Hisham O Akbar; Mohammed Babatin; Abdullah S Alghamdi; Mohammed I Dgdgi; Mohamed A Hamid; Yousef A Qari; Sherif A El-Kafrawy
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

4.  Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia.

Authors:  Ibrahim Al-Traif; Amjad Ali; Mutasim Dafalla; Waleed Al-Tamimi; Leila Qassem
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.